Details for 2017757375
Up to date per 03.04.2026
Actions
Details for 2017757375
Deleted
European Patent
02.01.2019 A
02.06.2021 B1
24.02.2016
US
201662299369 P
A61K 38/36 20060101AFI20200625BHEP
Owner
Alexion Pharmaceuticals, Inc.121 Seaport Boulevard Boston, MA 02210US
Representative
No representatives present
Inventor
NGUYEN, Phuong M.c/o Portola Pharmaceuticals Inc. 270 E. Grand Ave. Suite 22 South San Francisco California 94080US